Market Overview:
The global inhalation therapy nebuliser market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of respiratory diseases, growing awareness about inhalation therapy nebulisers, and technological advancements in the field of inhalation therapy nebulisers. Based on type, the global inhalation therapy nebuliser market is segmented into pneumatic nebulisers, ultrasonic nebulisers, and mesh nebulisers. Pneumatic Nebuliser dominates the global inhalation therapy Nebulizer Market with a share of more than 60%. Ultrasonic Nebulizers are witnessing high adoption rates due to their features such as low noise levels and portability.
Product Definition:
Inhalation Therapy Nebuliser is a device that converts medication from a liquid to a mist or aerosol that can be breathed in. It is used to deliver asthma medications, inhaled corticosteroids, and other respiratory medications. Inhalation therapy nebulisers are important because they improve the delivery of medication to the lungs, which helps reduce symptoms and improve lung function.
Pneumatic Nebuliser:
Pneumatic nebuliser is a device used to deliver medication in asthma, COPD and cystic fibrosis by creating a vacuum that draws the drug into the lungs. The pneumatic nebulizer delivers drugs in liquid form or suspension to patients suffering from respiratory disorders such as asthma, bronchitis & emphysema.
The pneumatic nebulizers are classified into two types on the basis of their size.
Ultrasonic Nebuliser:
The ultrasonic nebuliser is a device used to deliver medication by inhalation through the lungs. It works on the principle of producing and directing high frequency ultrasound vibrations which break drug into small particles, which are then absorbed by lung cells. Ultrasonic Nebuliser has several applications such as in Chronic Obstructive Pulmonary Disease (COPD), asthma, cystic fibrosis and others.
Application Insights:
The chronic Obstructive Pulmonary Disease (COPD) segment dominated the global inhalation therapy nebuliser market in 2017. This is owing to the increasing prevalence of COPD and other lung diseases such as bronchitis, emphysema and asthma. According to a study conducted by the Global Burden of Disease Project, an estimated 617 million people were suffering from COPD worldwide in 2016. It also reported that about three quarters of them were located in Asia Pacific region.
In addition, a large number of products are gaining approval for use in patients with COPD or at risk for developing this condition due to smoking-related damage to lungs over long term period owing to which these patients suffer from breathlessness even after taking proper medication course thus driving demand for inhalation therapy nebulizers over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing awareness about respiratory diseases, availability of highly skilled physicians and advanced healthcare infrastructure. Moreover, rising preference for technologically advanced devices is also expected to drive the demand for IN inhalation therapy nebulisers over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare facilities and economic development in emerging countries such as India and China.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global inhalation therapy nebuliser market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
- Technological advancements: The development of novel technologies in inhalation therapy nebulisers is expected to drive the market growth during the forecast period. For instance, in February 2017, PARI Medical introduced its new product “G3” which is an advanced electronic vibrating mesh technology-based nebuliser that offers high performance and reliability with low medication costs.
- Rising demand for home-based treatment: There has been a rising trend among patients towards home-based treatment for respiratory diseases instead of hospitalisation or clinic visits. This is attributed to factors such as increased affordability and convenience offered by home-based treatments coupled with growing awareness about these treatments among patients and caregivers alike . Inhalation therapy nebulisers are increasingly being used for home-based treatment owing to their ease of use and portability . This is likely to fuel market growth during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Inhalation Therapy Nebuliser Market Research Report
By Type
Pneumatic Nebuliser, Ultrasonic Nebuliser, Mesh Nebuliser
By Application
COPD, Cystic Fibrosis, Asthma, Others
By Companies
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Inhalation Therapy Nebuliser Market Report Segments:
The global Inhalation Therapy Nebuliser market is segmented on the basis of:
Types
Pneumatic Nebuliser, Ultrasonic Nebuliser, Mesh Nebuliser
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
COPD, Cystic Fibrosis, Asthma, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PARI GmbH
- Omron
- Drive DeVilbiss Healthcare
- Philips
- Yuwell
- Leyi
- Folee
- Medel S.p.A
- Briggs Healthcare
- 3A Health Care
- Trudell Medical International
- GF Health Products
Highlights of The Inhalation Therapy Nebuliser Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pneumatic Nebuliser
- Ultrasonic Nebuliser
- Mesh Nebuliser
- By Application:
- COPD
- Cystic Fibrosis
- Asthma
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inhalation Therapy Nebuliser Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An inhalation therapy nebuliser is a medical device that helps patients breathe easier by delivering medication or air directly to the lungs. Nebulisers are often used to treat conditions such as asthma, COPD, and cystic fibrosis.
Some of the major players in the inhalation therapy nebuliser market are PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, Trudell Medical International, GF Health Products.
The inhalation therapy nebuliser market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Inhalation Therapy Nebuliser Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Inhalation Therapy Nebuliser Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Inhalation Therapy Nebuliser Market - Supply Chain
4.5. Global Inhalation Therapy Nebuliser Market Forecast
4.5.1. Inhalation Therapy Nebuliser Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Inhalation Therapy Nebuliser Market Size (000 Units) and Y-o-Y Growth
4.5.3. Inhalation Therapy Nebuliser Market Absolute $ Opportunity
5. Global Inhalation Therapy Nebuliser Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Inhalation Therapy Nebuliser Market Size and Volume Forecast by Type
5.3.1. Pneumatic Nebuliser
5.3.2. Ultrasonic Nebuliser
5.3.3. Mesh Nebuliser
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Inhalation Therapy Nebuliser Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Inhalation Therapy Nebuliser Market Size and Volume Forecast by Application
6.3.1. COPD
6.3.2. Cystic Fibrosis
6.3.3. Asthma
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Inhalation Therapy Nebuliser Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Inhalation Therapy Nebuliser Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Inhalation Therapy Nebuliser Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Inhalation Therapy Nebuliser Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Inhalation Therapy Nebuliser Demand Share Forecast, 2019-2026
9. North America Inhalation Therapy Nebuliser Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Inhalation Therapy Nebuliser Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Inhalation Therapy Nebuliser Market Size and Volume Forecast by Application
9.4.1. COPD
9.4.2. Cystic Fibrosis
9.4.3. Asthma
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Inhalation Therapy Nebuliser Market Size and Volume Forecast by Type
9.7.1. Pneumatic Nebuliser
9.7.2. Ultrasonic Nebuliser
9.7.3. Mesh Nebuliser
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Inhalation Therapy Nebuliser Demand Share Forecast, 2019-2026
10. Latin America Inhalation Therapy Nebuliser Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Inhalation Therapy Nebuliser Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Inhalation Therapy Nebuliser Market Size and Volume Forecast by Application
10.4.1. COPD
10.4.2. Cystic Fibrosis
10.4.3. Asthma
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Inhalation Therapy Nebuliser Market Size and Volume Forecast by Type
10.7.1. Pneumatic Nebuliser
10.7.2. Ultrasonic Nebuliser
10.7.3. Mesh Nebuliser
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Inhalation Therapy Nebuliser Demand Share Forecast, 2019-2026
11. Europe Inhalation Therapy Nebuliser Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Inhalation Therapy Nebuliser Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Inhalation Therapy Nebuliser Market Size and Volume Forecast by Application
11.4.1. COPD
11.4.2. Cystic Fibrosis
11.4.3. Asthma
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Inhalation Therapy Nebuliser Market Size and Volume Forecast by Type
11.7.1. Pneumatic Nebuliser
11.7.2. Ultrasonic Nebuliser
11.7.3. Mesh Nebulser
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Inhalation Therapy Nebuliser Demand Share, 2019-2026
12. Asia Pacific Inhalation Therapy Nebuliser Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Inhalation Therapy Nebuliser Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Inhalation Therapy Nebuliser Market Size and Volume Forecast by Application
12.4.1. COPD
12.4.2. Cystic Fibrosis
12.4.3. Asthma
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Inhalation Therapy Nebuliser Market Size and Volume Forecast by Type
12.7.1. Pneumatic Nebuliser
12.7.2. Ultrasonic Nebuliser
12.7.3. Mesh Nebuliser
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Inhalation Therapy Nebuliser Demand Share, 2019-2026
13. Middle East & Africa Inhalation Therapy Nebuliser Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Inhalation Therapy Nebuliser Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Inhalation Therapy Nebuliser Market Size and Volume Forecast by Application
13.4.1. COPD
13.4.2. Cystic Fibrosis
13.4.3. Asthma
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Inhalation Therapy Nebuliser Market Size and Volume Forecast by Type
13.7.1. Pneumatic Nebuliser
13.7.2. Ultrasonic Nebuliser
13.7.3. Mesh Nebuliser
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Inhalation Therapy Nebuliser Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Inhalation Therapy Nebuliser Market: Market Share Analysis
14.2. Inhalation Therapy Nebuliser Distributors and Customers
14.3. Inhalation Therapy Nebuliser Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. PARI GmbH
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Omron
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Drive DeVilbiss Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Philips
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Yuwell
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Leyi
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Folee
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medel S.p.A
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Briggs Healthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. 3A Health Care
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Trudell Medical International
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GF Health Products
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
